Trastuzumab and catheter related complication Patient Reports March 21, 2010



Trastuzumab Side Effects Report #5115303-5
Trastuzumab side effect was reported by a Physician from AUSTRALIA on Mar 14, 2006. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, chest pain What is  chest pain, diarrhoea, dyspnoea, pyrexia, staphylococcal infection What is  staphylococcal infection. Trastuzumab dosage: 2 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NAVELBINE, CAPECITABINE, TRAMADOL, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5128130-X
Trastuzumab side effect was reported by a Pharmacist from AUSTRALIA on Sept 21, 2006. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, central line infection, chest pain What is  chest pain, diarrhoea, dyspnoea, haemoglobin decreased, staphylococcal infection What is  staphylococcal infection, thrombosis, white blood cell count decreased. Trastuzumab dosage: 2 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NAVELBINE, CAPECITABINE, TRAMADOL, ESOMEPRAZOLE, MAXOLON. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #4705447-1
Trastuzumab side effect was reported by a Consumer or non-health professional from on June 09, 2005. Female patient, 46 years of age, weighting 127.9 lb, was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: blood glucose increased, blood urea increased, cardiac disorder, catheter related complication, haemoglobin decreased, mass, neutrophil percentage increased, thrombosis in device, white blood cell count increased. Trastuzumab dosage: 348 MG/DAY IV. During the same period patient was treated with PERFALGAN. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #4705566-X
Trastuzumab side effect was reported by a Consumer or non-health professional from on Jan 27, 2005. Female patient, 46 years of age, weighting 127.9 lb, was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, international normalised ratio decreased, intracardiac thrombus, mass. Trastuzumab dosage: 348 MG/DAY IV. During the same period patient was treated with PERFALGAN. Patient was hospitalized. Patient recovered.


Trastuzumab Side Effects Report #4705570-1
Trastuzumab side effect was reported by a Consumer or non-health professional from on Sept 22, 2004. Female patient, 46 years of age, weighting 127.9 lb, was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, thrombosis in device. Trastuzumab dosage: 348 MG/DAY IV. During the same period patient was treated with PERFALGAN. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Trastuzumab